Skip to content

Effect of Rehabilitation at Moderate Altitude on Airway Resistance Measured With Forced Oscillation Technique in COPD-patients

Effect of Rehabilitation at Moderate Altitude on Airway Resistance Measured With Forced Oscillation Technique in Patients With COPD

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07063563
Enrollment
52
Registered
2025-07-14
Start date
2025-07-23
Completion date
2025-12-31
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Keywords

Oxygen, Exercise, Rehabilitation

Brief summary

Airway resistance will be measured using the forced oscillation technique (FOT). The parameters Rrs, Xrs, and ∆Xrs will be compared before and after a pulmonary rehabilitation cycle at moderate altitude. Additionally, the differences between low and moderate altitude will also be examined.

Interventions

OTHERambiant air

Standard ambiant air will be breathed during endurance training. ambiant air

OTHEROxygen

SSOT and sham air (5l/min) will be applied with the oxygen concentrator EverFloTM via nasal cannula during training

Sponsors

Eastern Switzerland University of Applied Sciences
Lead SponsorOTHER
National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov
CollaboratorOTHER_GOV
University of Zurich
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged ≥18 years * Stable clinical condition for \>3 weeks (e.g., no exacerbations) * Resting SpO₂ ≥88% and exercise-induced hypoxemia defined as a drop in SpO₂ of ≥4% and/or a level below 90% during the 6MWT * Informed consent documented by signature

Exclusion criteria

* Severe daytime resting hypoxemia (SpO₂ \<88%) * Long-term oxygen therapy * Unstable clinical condition requiring adjustment of pharmacological or other treatment modalities, need for intensive care, or presence of relevant severe comorbidities * Inability to comply with study procedures (e.g., due to language barriers, psychological disorders, neurological or orthopedic impairments, walking disability, or inability to ride a bicycle) * Women who are pregnant or breastfeeding * Enrolment in another clinical trial involving active treatment

Design outcomes

Primary

MeasureTime frameDescription
1. Change in Rrs (Respiratory System Resistance) before and after rehabilitation cyclebaseline to 3 weeksRrs will be measured using the forced oscillation technique (FOT) in cmH₂O·s/L. Values will be assessed before and after the pulmonary rehabilitation cycle at moderate altitude

Secondary

MeasureTime frameDescription
Change in Xrs (Respiratory System Reactance) compared before and after the pulmonary rehabilitation.baseline to 3 weeksXrs will be measured using FOT in cmH₂O·s/L. Values will be compared before and after the pulmonary rehabilitation
Change in ∆Xrs (Difference in Reactance) before and after rehabilitationbaseline to 3 weeks∆Xrs will be calculated as the difference between inspiratory and expiratory Xrs values, measured in cmH₂O·s/L, before and after rehabilitation.
Change in Rrs, Xrs and ∆Xrs from low to moderate altitudeFrom baseline at low altitude to transfer to moderate altitude at 3 days

Countries

Kyrgyzstan, Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026